New malaria drug works in infants

Oct 19, 2007

Scientists say a new malaria vaccine being tested in Mozambique was successful in protecting infants less than 1 year old.

The study, published in The Lancet, was intended to show the safety of the vaccine. GlaxoSmithKline researchers also found that the full course of three shots reduced the risk of catching malaria by 65 percent, The New York Times said.

The efficacy data is consistent with the estimate of 45 percent reduction in new infections reported in a 2004 trial in Mozambique among children one to four years old, GlaxoSmithKline said Thursday in a release.

"We're now a step closer to the realization of a vaccine that can protect African infants," said Dr. Pedro Alonso, the University of Barcelona professor who leads clinical trials of the vaccine.

Copyright 2007 by United Press International

Explore further: Clinical trial of Auxilium's Xiaflex shows it to be effective in smoothing cellulite

add to favorites email to friend print save as pdf

Related Stories

Vaccines on horizon for AIDS, Alzheimer's, herpes

Nov 17, 2009

(AP) -- Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working ...

Pulling malaria from mosquitoes to fight disease

Jun 08, 2009

(AP) -- Think your job's tedious? Try beheading 100 mosquitoes an hour. Gently, no smushing allowed. Malaria parasites lurk in these mosquitoes' salivary glands, and a small company on the outskirts of the ...

Recommended for you

Using computers to design drugs

3 hours ago

Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the ...

Lilly psoriasis drug fares well in late-stage test

8 hours ago

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

New US restrictions on painkiller to take effect

21 hours ago

The federal government is finalizing new restrictions on hundreds of medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S.

User comments : 0